Who are we?
Aptus Clinical is a specialist UK-based Clinical Contract Research Organisation (CRO) with particular expertise in oncology, rare diseases and advanced therapies. We are proud to be part of iMATCH, a Manchester-based consortium which is one of only three centres in the UK to be awarded funding by Innovate UK to coordinate scale-up of advanced therapies for a range of debilitating conditions.
In partnering with life science companies, we can help transform promising molecules into valued medicines. We ensure early clinical development strategies are optimised and that Phase I/II studies are both innovatively designed and expertly delivered.
Here is a brief potted history of how we got here: